TENX - Tenax Therapeutics to execute 1-for-20 reverse stock split

• Tenax Therapeutics ( NASDAQ: TENX ) is set to implement a 1-for-20 reverse stock split of its outstanding shares of common stock.
• Every 20 shares of company common stock will be automatically combined into one share of common stock.
• The split, which will become effective at 5:00 pm ET on January 4, 2023, is intended to bring the company into compliance with Nasdaq’s minimum bid price requirement.
• The common stock will begin trading on the Nasdaq Capital Market on a split-adjusted basis beginning upon market open on January 5, 2023, under the company's existing trading symbol "TENX."
• The reverse stock split will reduce the number of shares of common stock issued and outstanding from 45,836,215 to ~2,291,811.

For further details see: